T2 Biosystems is an American company, established in 2006 developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths – and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics.
T2Dx Instrument:
T2 Resistance Panel* :
Gram-negative species.
Gram-positive species.
T2Bacteria Panel:
95.8% Sensitivity**
98.2% Specificity.
T2Bacteria Panel:
91.1% Sensitivity
99.4% Specificity.